SLCO1B1 and CYP3A4 allelic variants associated with pharmacokinetic interactions and adverse reactions induced by simvastatin and atorvastatin used in Peru: Clinical implications

Context: Statins reduce the risk of stroke and prevent cardiac events in people with atherosclerosis and diabetes mellitus; and could affect the proliferation, migration, and survival of cancer cells. Aims: To review the most up-to-date and available scientific evidence on the allelic variants of...

Descripció completa

Dades bibliogràfiques

Autors principals:	Angel T. Alvarado, Ana María Muñoz, Roberto O. Ybañez-Julca, Mario Pineda-Pérez, Nesquen Tasayco-Yataco, María R. Bendezú, Jorge A. García, Felipe Surco-Laos, Haydee Chávez, Doris Laos-Anchante, Aura Molina-Cabrera, Carmela Ferreyra-Paredes, Nelly Vega-Ramos, Patricia Castillo-Romero, Javier Chávez-Espinoza, Juan Panay-Centeno, Eliades Yarasca-Carlos
Format:	Artigo
Idioma:	Inglês
Publicat:	GarVal Editorial Ltda. 2023-11-01
Col·lecció:	Journal of Pharmacy & Pharmacognosy Research
Matèries:	adverse reactions atorvastatin cyp3a4 pharmacokinetic interactions slco1b1 simvastatin
Accés en línia:	https://jppres.com/jppres/pdf/vol11/jppres23.1686_11.6.934.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!